5SK2
Crystal Structure of human phosphodiesterase 10 in complex with 2-(4-fluorophenyl)-4-(2-isoquinolin-3-yloxyethyl)-5-methyl-1,3-oxazole
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2010-10-15 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 0.999900 |
Spacegroup name | H 3 |
Unit cell lengths | 135.335, 135.335, 235.407 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 43.530 - 2.140 |
R-factor | 0.1811 |
Rwork | 0.179 |
R-free | 0.22910 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | inhouse model |
RMSD bond length | 0.011 |
RMSD bond angle | 1.702 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 43.530 | 43.530 | 2.200 |
High resolution limit [Å] | 2.140 | 9.570 | 2.140 |
Rmerge | 0.097 | 0.029 | 1.309 |
Rmeas | 0.109 | 0.033 | 1.453 |
Total number of observations | 455471 | ||
Number of reflections | 88623 | 984 | 6556 |
<I/σ(I)> | 11.16 | 39.55 | 1.28 |
Completeness [%] | 99.9 | 98.3 | 100 |
Redundancy | 5.139 | 4.72 | 5.304 |
CC(1/2) | 0.998 | 0.999 | 0.426 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 295 | 5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2 |